r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

JS

John W. Smither

Insider · Director · NAMS

John W. Smither files insider transactions with the SEC as a director of NewAmsterdam Pharma Co. We hold 2 disclosed purchases and sales filed since 12 February 2013, 2 of them in the last 90 days.

  • Files for 10 companiesNAMS, MBX, GNLX, ARQT and 6 more
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure9 September 2026

Positions held

10 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 January 2024 — 4 September 2026Director · NewAmsterdam Pharma Co 8 Form 4 lines · source: SEC Form 4
  • Filed 3 August 2026 — 3 August 2026Chief Financial Officer · MBX Biosciences 2 Form 4 lines · source: SEC Form 4
  • Filed 11 September 2023 — 1 July 2026Director · Genelux 13 Form 4 lines · source: SEC Form 4
  • Filed 27 February 2020 — 13 February 2024Chief Financial Officer · Arcutis Biotherapeutics 38 Form 4 lines · source: SEC Form 4
  • Filed 27 January 2022 — 27 December 2023Director · Applied Molecular Transport 6 Form 4 lines · source: SEC Form 4
  • Filed 25 August 2021 — 22 June 2023Director · eFFECTOR Therapeutics 7 Form 4 lines · source: SEC Form 4
  • Filed 19 February 2019 — 19 February 2019Director · Principia Biopharma 1 Form 4 line · source: SEC Form 4
  • Filed 16 April 2018 — 1 January 2019Chief Financial Officer · Sienna Biopharmaceuticals 6 Form 4 lines · source: SEC Form 4
  • Filed 11 March 2014 — 5 June 2018Director · Achaogen 5 Form 4 lines · source: SEC Form 4
  • Filed 29 January 2013 — 1 October 2015Chief Financial Officer · Kythera Biopharmaceuticals 120 Form 4 lines · source: SEC Form 4

Every transaction

206 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
206 of 206 shown
4 Sep 20269 Sep 2026SEC Form 45 dsold on the open marketNewAmsterdam Pharma Co1,600 sharesdown −10.3%up +0.0%
3 Aug 20264 Aug 2026SEC Form 41 dwas grantednot a tradeMBX Biosciences28,000 sharesdown −2.3%down −11.0%
3 Aug 20264 Aug 2026SEC Form 41 dwas grantednot a tradeMBX Biosciencesderivative130,000 sharesdown −2.3%down −11.0%
1 Jul 20262 Jul 2026SEC Form 41 dsold on the open marketGenelux12,000 sharesdown −13.1%down −15.7%
16 Jun 202618 Jun 2026SEC Form 42 dwas grantednot a tradeGenelux28,409 sharesdown −16.8%down −15.0%
16 Jun 202618 Jun 2026SEC Form 42 dwas grantednot a tradeGeneluxderivative31,566 sharesdown −16.8%down −15.0%
7 Jan 20269 Jan 2026SEC Form 42 dwas grantednot a tradeNewAmsterdam Pharma Co3,400 sharesdown −35.7%down −33.7%
7 Jan 20269 Jan 2026SEC Form 42 dwas grantednot a tradeNewAmsterdam Pharma Coderivative15,300 sharesdown −35.7%down −33.7%
7 Jan 20269 Jan 2026SEC Form 42 dwas grantednot a tradeNewAmsterdam Pharma Coderivative15,300 sharesdown −35.7%down −33.7%
7 Jan 20269 Jan 2026SEC Form 42 dwas grantednot a tradeNewAmsterdam Pharma Co3,400 sharesdown −35.7%down −33.7%
27 Aug 202529 Aug 2025SEC Form 42 dwas grantednot a tradeGeneluxderivative28,576 sharesdown −30.8%down −24.3%
27 Aug 202529 Aug 2025SEC Form 42 dwas grantednot a tradeGenelux22,283 sharesdown −30.8%down −24.3%
7 Jan 20258 Jan 2025SEC Form 41 dwas grantednot a tradeNewAmsterdam Pharma Co6,960 sharesdown −12.5%down −10.8%
6 Jan 20258 Jan 2025SEC Form 42 dwas grantednot a tradeNewAmsterdam Pharma Coderivative32,500 sharesdown −11.8%down −10.8%
1 Aug 202431 Dec 2024SEC Form 4152 dwas grantednot a tradeGeneluxderivative50,469 sharesup +28.6%up +6.8%
1 Aug 20245 Aug 2024SEC Form 44 dwas grantednot a tradeGeneluxderivative50,469 sharesup +28.6%up +55.6%
1 Aug 20245 Aug 2024SEC Form 44 dwas grantednot a tradeGenelux39,541 sharesup +28.6%up +55.6%
29 May 20247 Jun 2024SEC Form 49 dbought on the open marketnot a tradeGeneluxderivative6,250 sharesdown −10.0%up +10.5%
29 May 20247 Jun 2024SEC Form 49 dbought on the open marketGenelux6,250 sharesdown −10.0%up +10.5%
13 Feb 202415 Feb 2024SEC Form 42 dreturned to the issuernot a tradeArcutis Biotherapeuticsderivative8,379 sharesup +245.5%up +199.1%
13 Feb 202415 Feb 2024SEC Form 42 dreturned to the issuernot a tradeArcutis Biotherapeuticsderivative25,718 sharesup +245.5%up +199.1%
13 Feb 202415 Feb 2024SEC Form 42 dwas grantednot a tradeArcutis Biotherapeutics2,793 sharesup +245.5%up +199.1%
13 Feb 202415 Feb 2024SEC Form 42 dwas grantednot a tradeArcutis Biotherapeutics8,572 sharesup +245.5%up +199.1%
1 Jan 20243 Jan 2024SEC Form 42 dwas grantednot a tradeNewAmsterdam Pharma Coderivative10,000 sharesup +104.0%up +88.8%
27 Dec 202328 Dec 2023SEC Form 41 dreturned to the issuernot a tradeAMTIApplied Molecular Transportderivative60,000 shares——
27 Dec 202328 Dec 2023SEC Form 41 dreturned to the issuernot a tradeAMTIApplied Molecular Transportderivative20,000 shares——
13 Sep 202314 Sep 2023SEC Form 41 dsold on the open marketGenelux900 sharesdown −88.1%down −88.6%
11 Sep 202313 Sep 2023SEC Form 42 dwas grantednot a tradeGeneluxderivative8,447 sharesdown −88.7%down −88.1%
11 Sep 202313 Sep 2023SEC Form 42 dwas grantednot a tradeGenelux6,920 sharesdown −88.7%down −88.1%
31 Aug 20235 Sep 2023SEC Form 45 dwas grantednot a tradeArcutis Biotherapeuticsderivative125,000 sharesup +179.2%up +187.9%
22 Jun 202322 Jun 2023SEC Form 40 dwas grantednot a tradeEFTReFFECTOR Therapeuticsderivative20,000 shares——
14 Jun 202315 Jun 2023SEC Form 41 dwas grantednot a tradeAMTIApplied Molecular Transportderivative20,000 shares——
20 Jan 202324 Jan 2023SEC Form 44 dwas grantednot a tradeEFTReFFECTOR Therapeuticsderivative36,875 shares——
9 Jun 202213 Jun 2022SEC Form 44 dwas grantednot a tradeEFTReFFECTOR Therapeuticsderivative20,000 shares——
24 May 202228 Dec 2023SEC Form 4583 dreturned to the issuernot a tradeAMTIApplied Molecular Transportderivative20,000 shares——
24 May 202226 May 2022SEC Form 42 dwas grantednot a tradeAMTIApplied Molecular Transportderivative20,000 shares——
27 Jan 202231 Jan 2022SEC Form 44 dwas grantednot a tradeAMTIApplied Molecular Transportderivative60,000 shares——
6 Oct 20218 Oct 2021SEC Form 42 dwas grantednot a tradeEFTReFFECTOR Therapeuticsderivative40,000 shares——
25 Aug 202127 Aug 2021SEC Form 42 dwas grantednot a tradeEFTReFFECTOR Therapeuticsderivative24,142 shares——
25 Aug 202127 Aug 2021SEC Form 42 dwas grantednot a tradeEFTReFFECTOR Therapeuticsderivative3,556 shares——
25 Aug 202127 Aug 2021SEC Form 42 dwas grantednot a tradeEFTReFFECTOR Therapeutics24,142 shares——
10 Mar 202111 Mar 2021SEC Form 41 dexercised options overnot a tradeArcutis Biotherapeuticsderivative500 sharesdown −26.0%down −27.4%
10 Mar 202111 Mar 2021SEC Form 41 dexercised options overnot a tradeArcutis Biotherapeutics500 sharesdown −26.0%down −27.4%
10 Mar 202111 Mar 2021SEC Form 41 dsold on the open marketArcutis Biotherapeutics500 sharesdown −26.0%down −27.4%
10 Mar 202111 Mar 2021SEC Form 41 dsold on the open marketArcutis Biotherapeutics1,250 sharesdown −26.0%down −27.4%
4 Mar 20215 Mar 2021SEC Form 41 dexercised options overnot a tradeArcutis Biotherapeuticsderivative12,396 sharesdown −22.3%down −23.7%
4 Mar 20215 Mar 2021SEC Form 41 dexercised options overnot a tradeArcutis Biotherapeutics12,396 sharesdown −22.3%down −23.7%
3 Mar 20215 Mar 2021SEC Form 42 dwas grantednot a tradeArcutis Biotherapeuticsderivative28,800 sharesdown −26.5%down −23.7%
3 Mar 20215 Mar 2021SEC Form 42 dwas grantednot a tradeArcutis Biotherapeutics9,500 sharesdown −26.5%down −23.7%
1 Mar 20213 Mar 2021SEC Form 42 dsold on the open marketArcutis Biotherapeutics773 sharesdown −31.8%down −26.5%
10 Feb 202112 Feb 2021SEC Form 42 dexercised options overnot a tradeArcutis Biotherapeuticsderivative750 sharesdown −34.0%down −32.0%
10 Feb 202112 Feb 2021SEC Form 42 dexercised options overnot a tradeArcutis Biotherapeutics750 sharesdown −34.0%down −32.0%
10 Feb 202112 Feb 2021SEC Form 42 dsold on the open marketArcutis Biotherapeutics750 sharesdown −34.0%down −32.0%
10 Feb 202112 Feb 2021SEC Form 42 dsold on the open marketArcutis Biotherapeutics2,000 sharesdown −34.0%down −32.0%
1 Feb 20213 Feb 2021SEC Form 42 dexercised options overnot a tradeArcutis Biotherapeutics1,250 sharesdown −33.0%down −31.2%
1 Feb 20213 Feb 2021SEC Form 42 dsold on the open marketArcutis Biotherapeutics1,250 sharesdown −33.0%down −31.2%
1 Feb 20213 Feb 2021SEC Form 42 dsold on the open marketArcutis Biotherapeutics3,750 sharesdown −33.0%down −31.2%
1 Feb 20213 Feb 2021SEC Form 42 dexercised options overnot a tradeArcutis Biotherapeuticsderivative1,250 sharesdown −33.0%down −31.2%
19 Jan 202121 Jan 2021SEC Form 42 dexercised options overnot a tradeArcutis Biotherapeutics500 sharesdown −17.0%down −12.4%
19 Jan 202121 Jan 2021SEC Form 42 dsold on the open marketArcutis Biotherapeutics500 sharesdown −17.0%down −12.4%
19 Jan 202121 Jan 2021SEC Form 42 dsold on the open marketArcutis Biotherapeutics1,250 sharesdown −17.0%down −12.4%
19 Jan 202121 Jan 2021SEC Form 42 dexercised options overnot a tradeArcutis Biotherapeuticsderivative500 sharesdown −17.0%down −12.4%
14 Dec 202016 Dec 2020SEC Form 42 dexercised options overnot a tradeArcutis Biotherapeuticsderivative1,500 sharesdown −18.2%down −23.9%
14 Dec 202016 Dec 2020SEC Form 42 dexercised options overnot a tradeArcutis Biotherapeutics1,500 sharesdown −18.2%down −23.9%
14 Dec 202016 Dec 2020SEC Form 42 dsold on the open marketArcutis Biotherapeutics1,500 sharesdown −18.2%down −23.9%
14 Dec 202016 Dec 2020SEC Form 42 dsold on the open marketArcutis Biotherapeutics3,750 sharesdown −18.2%down −23.9%
29 Sep 20201 Oct 2020SEC Form 42 dexercised options overnot a tradeArcutis Biotherapeuticsderivative500 sharesdown −23.2%down −13.7%
29 Sep 20201 Oct 2020SEC Form 42 dexercised options overnot a tradeArcutis Biotherapeutics500 sharesdown −23.2%down −13.7%
29 Sep 20201 Oct 2020SEC Form 42 dsold on the open marketArcutis Biotherapeutics500 sharesdown −23.2%down −13.7%
29 Sep 20201 Oct 2020SEC Form 42 dsold on the open marketArcutis Biotherapeutics1,250 sharesdown −23.2%down −13.7%
11 Jun 202015 Jun 2020SEC Form 44 dexercised options overnot a tradeArcutis Biotherapeuticsderivative14,875 sharesdown −6.7%down −19.1%
11 Jun 202015 Jun 2020SEC Form 44 dexercised options overnot a tradeArcutis Biotherapeutics14,875 sharesdown −6.7%down −19.1%
27 Feb 20203 Mar 2020SEC Form 45 dwas grantednot a tradeArcutis Biotherapeuticsderivative12,000 sharesdown −13.7%down −13.2%
27 Feb 20203 Mar 2020SEC Form 45 dwas grantednot a tradeArcutis Biotherapeutics9,000 sharesdown −13.7%down −13.2%
19 Feb 201921 Feb 2019SEC Form 42 dwas grantednot a tradePRNBPrincipia Biopharmaderivative20,475 shares——
1 Jan 20193 Jan 2019SEC Form 42 dwas grantednot a tradeSNNASienna Biopharmaceuticalsderivative14,422 shares——
1 Jan 20193 Jan 2019SEC Form 42 dwas grantednot a tradeSNNASienna Biopharmaceuticalsderivative22,500 shares——
1 Jan 20193 Jan 2019SEC Form 42 dwas grantednot a tradeSNNASienna Biopharmaceuticalsderivative22,500 shares——
1 Jan 20193 Jan 2019SEC Form 42 dwas grantednot a tradeSNNASienna Biopharmaceuticals45,000 shares——
15 Jul 201817 Jul 2018SEC Form 42 dwas grantednot a tradeSNNASienna Biopharmaceuticalsderivative20,000 shares——
5 Jun 20187 Jun 2018SEC Form 42 dwas grantednot a tradeAKAOAchaogenderivative15,000 shares——
16 Apr 201818 Apr 2018SEC Form 42 dwas grantednot a tradeSNNASienna Biopharmaceuticalsderivative170,000 shares——
14 Jun 201716 Jun 2017SEC Form 42 dwas grantednot a tradeAKAOAchaogenderivative10,000 shares——
15 Jun 201617 Jun 2016SEC Form 42 dwas grantednot a tradeAKAOAchaogenderivative10,000 shares——
1 Oct 20152 Oct 2015SEC Form 41 dreturned to the issuernot a tradeKythera Biopharmaceuticals17,960 shares——
1 Oct 20152 Oct 2015SEC Form 41 dreturned to the issuernot a tradeKythera Biopharmaceuticals6,216 shares——
1 Oct 20152 Oct 2015SEC Form 41 dreturned to the issuernot a tradeKythera Biopharmaceuticalsderivative14,897 shares——
1 Oct 20152 Oct 2015SEC Form 41 dreturned to the issuernot a tradeKythera Biopharmaceuticalsderivative852 shares——
1 Oct 20152 Oct 2015SEC Form 41 dreturned to the issuernot a tradeKythera Biopharmaceuticalsderivative6,700 shares——
1 Oct 20152 Oct 2015SEC Form 41 dreturned to the issuernot a tradeKythera Biopharmaceuticalsderivative19,266 shares——
1 Oct 20152 Oct 2015SEC Form 41 dreturned to the issuernot a tradeKythera Biopharmaceuticalsderivative45,344 shares——
25 Sep 201528 Sep 2015SEC Form 43 dexercised options overnot a tradeKythera Biopharmaceuticals14,017 shares——
25 Sep 201528 Sep 2015SEC Form 43 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative14,017 shares——
24 Sep 201524 Sep 2015SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals13,154 shares——
24 Sep 201524 Sep 2015SEC Form 40 dsold on the open marketKythera Biopharmaceuticals13,154 shares——
24 Sep 201524 Sep 2015SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals13,763 shares——
24 Sep 201524 Sep 2015SEC Form 40 dsold on the open marketKythera Biopharmaceuticals13,763 shares——
24 Sep 201524 Sep 2015SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative13,154 shares——
24 Sep 201524 Sep 2015SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative13,763 shares——
23 Sep 201524 Sep 2015SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals13,272 shares——
23 Sep 201524 Sep 2015SEC Form 41 dsold on the open marketKythera Biopharmaceuticals13,272 shares——
23 Sep 201524 Sep 2015SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals13,646 shares——
23 Sep 201524 Sep 2015SEC Form 41 dsold on the open marketKythera Biopharmaceuticals13,646 shares——
23 Sep 201524 Sep 2015SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative13,272 shares——
23 Sep 201524 Sep 2015SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative13,400 shares——
23 Sep 201524 Sep 2015SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative246 shares——
22 Sep 201523 Sep 2015SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals3,476 shares——
22 Sep 201523 Sep 2015SEC Form 41 dsold on the open marketKythera Biopharmaceuticals3,476 shares——
22 Sep 201523 Sep 2015SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals2,115 shares——
22 Sep 201523 Sep 2015SEC Form 41 dsold on the open marketKythera Biopharmaceuticals2,115 shares——
22 Sep 201523 Sep 2015SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative3,476 shares——
22 Sep 201523 Sep 2015SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative2,115 shares——
18 Sep 201523 Sep 2015SEC Form 45 dexercised options overnot a tradeKythera Biopharmaceuticals1,054 shares——
18 Sep 201523 Sep 2015SEC Form 45 dsold on the open marketKythera Biopharmaceuticals1,054 shares——
18 Sep 201523 Sep 2015SEC Form 45 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative1,054 shares——
26 Jun 201523 Sep 2015SEC Form 489 dgave awaynot a tradeKythera Biopharmaceuticals1,400 shares——
25 Jun 201530 Jun 2015SEC Form 45 dsold on the open marketKythera Biopharmaceuticals4,600 shares——
25 Jun 201525 Jun 2015SEC Form 40 dsold on the open marketKythera Biopharmaceuticals4,600 shares——
10 Jun 201511 Jun 2015SEC Form 41 dwas grantednot a tradeAKAOAchaogenderivative10,000 shares——
30 Apr 201523 Sep 2015SEC Form 4146 dsold on the open marketKythera Biopharmaceuticals2,041 shares——
30 Apr 201530 Apr 2015SEC Form 40 dsold on the open marketKythera Biopharmaceuticals2,041 shares——
29 Apr 201523 Sep 2015SEC Form 4147 dwas grantednot a tradeKythera Biopharmaceuticals5,409 shares——
29 Apr 201530 Apr 2015SEC Form 41 dwas grantednot a tradeKythera Biopharmaceuticals5,409 shares——
5 Mar 20155 Mar 2015SEC Form 40 dsold on the open marketKythera Biopharmaceuticals2,000 shares——
5 Mar 20155 Mar 2015SEC Form 40 dsold on the open marketKythera Biopharmaceuticals1,000 shares——
5 Mar 20155 Mar 2015SEC Form 40 dsold on the open marketKythera Biopharmaceuticals1,200 shares——
18 Feb 201519 Feb 2015SEC Form 41 dsold on the open marketKythera Biopharmaceuticals1,000 shares——
17 Feb 201519 Feb 2015SEC Form 42 dsold on the open marketKythera Biopharmaceuticals1,000 shares——
29 Jan 20153 Feb 2015SEC Form 45 dwas grantednot a tradeKythera Biopharmaceuticalsderivative45,344 shares——
29 Jan 20152 Feb 2015SEC Form 44 dsold on the open marketKythera Biopharmaceuticals1,000 shares——
29 Jan 20152 Feb 2015SEC Form 44 dwas grantednot a tradeKythera Biopharmaceuticalsderivative45,344 shares——
23 Jan 201527 Jan 2015SEC Form 44 dsold on the open marketKythera Biopharmaceuticals2,000 shares——
23 Jan 201527 Jan 2015SEC Form 44 dsold on the open marketKythera Biopharmaceuticals1,000 shares——
7 Jan 201527 Jan 2015SEC Form 420 dgave awaynot a tradeKythera Biopharmaceuticals6,216 shares——
5 Jan 20156 Jan 2015SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals6,216 shares——
5 Jan 20156 Jan 2015SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative6,216 shares——
22 Dec 201422 Dec 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals375 shares——
22 Dec 201422 Dec 2014SEC Form 40 dsold on the open marketKythera Biopharmaceuticals375 shares——
22 Dec 201422 Dec 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative375 shares——
20 Nov 201420 Nov 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals375 shares——
20 Nov 201420 Nov 2014SEC Form 40 dsold on the open marketKythera Biopharmaceuticals375 shares——
20 Nov 201420 Nov 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative375 shares——
20 Oct 201420 Oct 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals375 shares——
20 Oct 201420 Oct 2014SEC Form 40 dsold on the open marketKythera Biopharmaceuticals375 shares——
20 Oct 201420 Oct 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative375 shares——
22 Sep 201422 Sep 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals375 shares——
22 Sep 201422 Sep 2014SEC Form 40 dsold on the open marketKythera Biopharmaceuticals375 shares——
22 Sep 201422 Sep 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative375 shares——
20 Sep 201427 Jan 2015SEC Form 4129 dgave awaynot a tradeKythera Biopharmaceuticals16,200 shares——
20 Aug 201420 Aug 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals375 shares——
20 Aug 201420 Aug 2014SEC Form 40 dsold on the open marketKythera Biopharmaceuticals375 shares——
20 Aug 201420 Aug 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative375 shares——
21 Jul 201421 Jul 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals375 shares——
21 Jul 201421 Jul 2014SEC Form 40 dsold on the open marketKythera Biopharmaceuticals375 shares——
21 Jul 201421 Jul 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative375 shares——
2 Jul 20143 Jul 2014SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals2,250 shares——
2 Jul 20143 Jul 2014SEC Form 41 dsold on the open marketKythera Biopharmaceuticals2,250 shares——
2 Jul 20143 Jul 2014SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative2,250 shares——
20 Jun 201424 Jun 2014SEC Form 44 dexercised options overnot a tradeKythera Biopharmaceuticals375 shares——
20 Jun 201424 Jun 2014SEC Form 44 dsold on the open marketKythera Biopharmaceuticals375 shares——
20 Jun 201424 Jun 2014SEC Form 44 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative375 shares——
13 Jun 201416 Jun 2014SEC Form 43 dexercised options overnot a tradeKythera Biopharmaceuticals3,000 shares——
13 Jun 201416 Jun 2014SEC Form 43 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative3,000 shares——
20 May 201421 May 2014SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals375 shares——
20 May 201421 May 2014SEC Form 41 dsold on the open marketKythera Biopharmaceuticals375 shares——
20 May 201421 May 2014SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative375 shares——
21 Apr 201421 Apr 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals375 shares——
21 Apr 201421 Apr 2014SEC Form 40 dsold on the open marketKythera Biopharmaceuticals375 shares——
21 Apr 201421 Apr 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative375 shares——
26 Mar 201427 Mar 2014SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals3,000 shares——
26 Mar 201427 Mar 2014SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative3,000 shares——
20 Mar 201420 Mar 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals1,125 shares——
20 Mar 201420 Mar 2014SEC Form 40 dsold on the open marketKythera Biopharmaceuticals1,125 shares——
20 Mar 201420 Mar 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative1,125 shares——
11 Mar 201413 Mar 2014SEC Form 42 dwas grantednot a tradeAKAOAchaogenderivative10,000 shares——
20 Feb 201421 Feb 2014SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals2,250 shares——
20 Feb 201421 Feb 2014SEC Form 41 dsold on the open marketKythera Biopharmaceuticals2,250 shares——
20 Feb 201421 Feb 2014SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative2,250 shares——
14 Feb 201418 Feb 2014SEC Form 44 dexercised options overnot a tradeKythera Biopharmaceuticals1,125 shares——
14 Feb 201418 Feb 2014SEC Form 44 dsold on the open marketKythera Biopharmaceuticals1,125 shares——
14 Feb 201418 Feb 2014SEC Form 44 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative1,125 shares——
22 Jan 201413 Feb 2014SEC Form 422 dwas grantednot a tradeKythera Biopharmaceuticalsderivative33,029 shares——
21 Jan 201421 Jan 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals1,125 shares——
21 Jan 201421 Jan 2014SEC Form 40 dsold on the open marketKythera Biopharmaceuticals1,125 shares——
21 Jan 201421 Jan 2014SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative1,125 shares——
16 Dec 201316 Dec 2013SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative1,200 shares——
16 Dec 201316 Dec 2013SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals1,200 shares——
6 Nov 20137 Nov 2013SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative9,000 shares——
6 Nov 20137 Nov 2013SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals9,000 shares——
10 Sep 201310 Sep 2013SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative30,000 shares——
10 Sep 201310 Sep 2013SEC Form 40 dexercised options overnot a tradeKythera Biopharmaceuticals30,000 shares——
10 Sep 201310 Sep 2013SEC Form 40 dsold on the open marketKythera Biopharmaceuticals30,000 shares——
9 Sep 201310 Sep 2013SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative10,000 shares——
9 Sep 201310 Sep 2013SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals10,000 shares——
9 Sep 201310 Sep 2013SEC Form 41 dsold on the open marketKythera Biopharmaceuticals10,000 shares——
1 Aug 20132 Aug 2013SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative10,000 shares——
1 Aug 20132 Aug 2013SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals10,000 shares——
1 Aug 20132 Aug 2013SEC Form 41 dsold on the open marketKythera Biopharmaceuticals10,000 shares——
17 Jun 201318 Jun 2013SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative6,000 shares——
17 Jun 201318 Jun 2013SEC Form 41 dexercised options overnot a tradeKythera Biopharmaceuticals6,000 shares——
17 Jun 201318 Jun 2013SEC Form 41 dsold on the open marketKythera Biopharmaceuticals6,000 shares——
1 May 20133 May 2013SEC Form 42 dexercised options overnot a tradeKythera Biopharmaceuticalsderivative4,000 shares——
1 May 20133 May 2013SEC Form 42 dexercised options overnot a tradeKythera Biopharmaceuticals4,000 shares——
1 May 20133 May 2013SEC Form 42 dsold on the open marketKythera Biopharmaceuticals4,000 shares——
29 Jan 201312 Feb 2013SEC Form 414 dwas grantednot a tradeKythera Biopharmaceuticalsderivative20,100 shares——
29 Jan 201312 Feb 2013SEC Form 414 dwas grantednot a tradeKythera Biopharmaceuticalsderivative13,400 shares——

Both percentages are the stock’s move, not John W. Smither’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 9 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 61 of the 206 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.